Please assess the completion status of the following clinical trial:

Trial Title: Differential Effect of High (200μg/kg/Min) Adenosine Dose on Fractional Flow Reserve in Patients Presenting Variation of FFR ≥0.05 During the Usual Dose of Adenosine Infusion (140μg/kg/Min).

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18-80 years~2. Patients with at least 1 ≥50% stenosis in a coronary vessel, subjected to FFR assessment, who exhibit variation in Pd / Pa ratio ≥ 0.05 (e.g. difference of max Pd/Pa minus min Pd/Pa) during steady state hyperaemia (determined by visual assessment).~3. Written informed consent~Exclusion Criteria:~1. Left main disease (angiographically\> 50%)~2. Cardiogenic shock / hemodynamic instability~3. Previous CABG~4. Increased risk of bradycardia on investigator clinical judgment~5. Severe chronic obstructive pulmonary disease~6. Coronary vessels with tortuosity or extremely calcified~7. Severe left ventricular hypertrophy or severe valvular disease~8. STEMI or non-STEMI within the past five days~9. Previous myocardial infarction in the distribution of the target vessel for the FFR~10. Acute decompensated heart failure.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Adenosine intravenous infusion at 200μg/Kg/min (Type: EXPERIMENTAL): Fractional flow reserve assessment under Adenosine intravenous infusion at 200μg/Kg/min

Based on this trial design, predict the completion outcome and termination type (if applicable).